Skip to main content

solute carrier family 25 member 4

The SLC25A4 gene provides the instructions for making a protein called adenine nucleotide translocase type 1 (ANT1). ANT1 functions in mitochondria, which are structures within cells that convert the energy from food into a form that cells can use. This process, called oxidative phosphorylation, converts adenosine diphosphate (ADP) into adenosine triphosphate (ATP), the cell's main energy source. ANT1 forms a channel in the inner membrane of mitochondria. This channel allows ADP into mitochondria and ATP out of mitochondria to be used as energy for the cell. ANT1 may also be a part of another structure in the inner membrane called the mitochondrial permeability transition pore. This structure allows various molecules to pass into mitochondria and is thought to play a role in the self-destruction (apoptosis) of the cell.

Video picks for Genes
Video library

Normal function

The SLC25A4 gene provides the instructions for making a protein called adenine nucleotide translocase type 1 (ANT1). ANT1 functions in mitochondria, which are structures within cells that convert the energy from food into a form that cells can use. This process, called oxidative phosphorylation, converts adenosine diphosphate (ADP) into adenosine triphosphate (ATP), the cell's main energy source. ANT1 forms a channel in the inner membrane of mitochondria. This channel allows ADP into mitochondria and ATP out of mitochondria to be used as energy for the cell. ANT1 may also be a part of another structure in the inner membrane called the mitochondrial permeability transition pore. This structure allows various molecules to pass into mitochondria and is thought to play a role in the self-destruction (apoptosis) of the cell.

Conditions referring to this gene or chromosome

Other names

AAC1

adenine nucleotide translocator 1 (skeletal muscle)

ADP,ATP carrier protein 1

ADP,ATP carrier protein, heart/skeletal muscle

ADP/ATP translocase 1

ADT1_HUMAN

ANT

ANT 1

ANT1

heart/skeletal muscle ATP/ADP translocator

PEO2

PEO3

solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4

T1

Patient picks for Genes

Related patient information and medicines

Cystic fibrosis

Patient information leaflet

Cystic fibrosis

Cystic fibrosis is a genetic disorder. About 1 in 25 people in the UK of white European descent are carriers of the cystic fibrosis gene. When two people who carry the cystic fibrosis gene have a child, there is a: 1 in 4 chance that the child will have cystic fibrosis (by inheriting the cystic fibrosis gene from both parents). 2 in 4 chance that.

Haemochromatosis

Patient information leaflet

Haemochromatosis

...netic conditionWhen two people who carry the abnormal gene have a child, there is a: 1 in 4 chance that the child will have haemochromatosis (by inheriting the abnormal gene from both parents). 2 in 4 chance that the child will not have haemochromatosis but will be a carrier (by inheriting the abnormal gene from one parent but the normal gene.

Planning to become pregnant

Patient information leaflet

Planning to become pregnant

Screening tests Pregn... Some women may wish to have the screening test before becoming pregnant, especially if their family origins make these diseases more likely. People from families originating from Africa, the Caribbean, Southeast Asia, Sardinia, Greece, Turkey or Cyprus are more likely to have one of these conditions or to be a carrier for.

Hereditary spherocytosis

Patient information leaflet

Hereditary spherocytosis

Hereditary spherocytosis (HS) is an inherited condition of red blood cells. The disease can be mild and go unrecognised in some people. In others there may be severe anaemia requiring regular blood transfusions. Some people with hereditary spherocytosis may be offered surgery to remove their spleen. This usually helps the condition, but increases.

Wilson's disease

Patient information leaflet

Wilson's disease

When the copper storage capacity of the liver cells is exhausted, the copper spills into the bloodstream and deposits copper in other parts of the body, mainly the brain. How is Wilson's disease inherited. Wilson's disease is an autosomal recessive disorder. This means that, in order to develop Wilson's disease, two abnormal ATP7B genes must be.

Polycystic kidney disease

Patient information leaflet

Polycystic kidney disease

This is an hereditary condition caused by a faulty gene which is inherited from one parent. Autosomal recessive polycystic kidney disease (ARPKD) This is a rare condition which affects about 1 in 20,000 people. Although people with PKD often develop kidney failure (end-stage kidney disease) between ages 55 to 65 years, some people with PKD have a.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 2 May 2023 | Latest version
  • 1 May 2016 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.